The Administration has done important work to help lower drug prices, but the recent proposed rule on drug rebates – which would eliminate rebates and undermine the Pharmacy Benefit Managers (PBMs) that play a critical role in reducing prescription drug prices for patients – is a step in the wrong direction for American patients.

Instead of finding real solutions to root out the cause of out-of-control drug prices – price gouging by the pharmaceutical industry – this plan would be the newest Big Pharma bailout – allowing spending to go straight to big drug makers.

These are the facts:

The truth is – we need market-based solutions that focus on actually lowering drug prices by holding Big Pharma accountable, fostering competition and reinforcing value. Learn more here.

Tell your legislators: Stop the Big Pharma Bailout!



And for a “Dose of Reality” – find out how Big Pharma’s price gouging is causing the drug pricing crisis and impacting patients here.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.